HOPCo (Healthcare Outcomes Performance Company), the leader in musculoskeletal (MSK) clinical outcomes management solutions and the country’s largest orthopedic value-based care organization, continues its digital health platform expansion with its acquisition of MyACTome. As the only validated smartphone-based fall risk and frailty assessment platform, MyACTome leverages the existing motion sensors within a smartphone to assess patient balance, walking dynamics, and dynamic stability patterns to quantify patient biomechanical performance, frailty score, and fall risk – allowing risk stratification of patients.
Read the full article: HOPCo Announces Acquisition of Digital Health Platform, MyACTome //
Source: https://hopco.com/hopco-announces-acquisition-of-digital-health-platform-myactome